Recent Decisions Affecting Patent Law

Similar documents
PATENT DISCLOSURE: Meeting Expectations in the USPTO

The Death of the Written Description Requirement? Analysis and Potential Outcomes of the Ariad Case

Written Description of the Invention: Ariad (2010) and the Overlooked Invention Priority Principle. Donald S. Chisum*

History of Written Description as Separate from Enablement. The purpose of the "written description" requirement is broader than to merely explain how

2010 PATENTLY O PATENT LAW JOURNAL

Kevin C. Adam* I. INTRODUCTION

Inducing Infringement: Inferring Knowledge and Intent from a Finding of Deliberate Indifference by Ronald J. Brown and Bridget M.

No IN THE. i I! GLOBAL-TECH APPLIANCES, INC., et al.,

Ending the Invalidity Shell Game: Stabilizing the Application of the Written Description Requirement in Patent Litigation

United States Court of Appeals for the Federal Circuit

In re Metoprolol Succinate Obviousness-Type Double Patenting Walter B. Welsh St. Onge Steward Johnston & Reens LLC Stamford, Connecticut

- F.3d, 2009 WL , C.A.Fed. (Mass.), April 03, 2009 (NO )

Intent Standard for Induced Patent Infringement: Global-Tech Appliances, Inc. v. SEB S.A.

Responding to Rejections

The Patent Examination Manual. Section 10: Meaning of useful. Meaning of useful. No clear statement of utility. Specific utility

THE DISTRICT COURT CASE

112 Requirements. January Disclosing A Genus Of Compounds. g Supporting A Negative Limitation By Disclosing A Reason To Exclude

United States Court of Appeals for the Federal Circuit

Patent Prosecution and Joint Ownership of United States Patents

Gilding the Lilly: The 112 Written Description Requirement Separate from Enablement

Petitioners, v. BECTON, DICKINSON & CO., Respondent. REPLY BRIEF FOR THE PETITIONERS

No LIMELIGHT NETWORKS, INC., AKAMAI TECHNOLOGIES, INC., et al., In The Supreme Court of the United States

Brian D. Coggio Ron Vogel. Should A Good Faith Belief In Patent Invalidity Negate Induced Infringement? (The Trouble with Commil is DSU)

Requirement: Lessons Learned Since Ariad v. Lilly Navigating Section 112 Disclosure Obligations and Withstanding Invalidity Challenges

Written Description. John B. Pegram FISH & RICHARDSON P.C. Paula K. Davis ELI LILLY AND COMPANY

PATENT, TRADEMARK & COPYRIGHT!

'Willful Blindness' And Induced Patent Infringement

United States Court of Appeals for the Federal Circuit

When Is An Invention. Nevertheless Nonobvious?

United States Court of Appeals

Induced and Divided Infringement: Updates and Strategic Views

35 U.S.C. 135 Gateway to Priority and Derivation Determinations by the BPAI

United States Court of Appeals for the Federal Circuit

The Toro Company v. White Consolidated Industries, Inc.

2017 U.S. LEXIS 1428, * 1 of 35 DOCUMENTS. LIFE TECHNOLOGIES CORPORATION, ET AL., PETITIONERS v. PROMEGA CORPORATION. No

v. Civil Action No RGA

United States Court of Appeals for the Federal Circuit

DEVELOPMENTS IN CLAIM CONSTRUCTION

United States Court of Appeals for the Federal Circuit

CHAPTER V PATENT SPECIFICATION AND CLAIMS

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit

This Webcast Will Begin Shortly

Phillips v. AWH Corporation Revisiting the Rules of Claim Construction: Still No Magic Formula

United States Court of Appeals for the Federal Circuit

PETITION FOR A WRIT OF CERTIORARI

Patent Claim Construction: Phillips v. AWH (Fed. Cir., July 12, 2005) (en banc) Edward D. Manzo August Patent in Suit

Paper 14 Tel: Entered: June 15, 2015 UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD

Information and Guidelines Concerning the Patent and Copyright Process at East Tennessee State University

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS DALLAS DIVISION

Case 1:14-cv LPS Document 583 Filed 09/01/17 Page 1 of 6 PageID #: IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

appropriate measure of damages to which plaintiff Janssen Biotech,

Supreme Court of the United States

IN THE MATTER OF REQUEST FOR COMMENTS AND NOTICE REGARDING PREPARATION OF PATENT APPLICATIONS. Docket No. PTO P

United States Court of Appeals for the Federal Circuit

SHARPLY DIVIDED EN BANC FEDERAL CIRCUIT REAFFIRMS APPLICATION OF A DE NOVO STANDARD OF REVIEW FOR CLAIM CONSTRUCTION

Second medical use or indication claims. Winnie Tham, Edmund Kok, Nicholas Ong

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit

HOW SHOULD COPIED CLAIMS BE INTERPRETED? 1. Charles L. Gholz 2. Two recent opinions tee up this issue nicely. They are Robertson v.

Seeking Patent Protection for Business-Related and Computer-Related Inventions After Bilski

Federal Circuit Provides Roadmap for Patent Actions at the ITC by Non-Practicing Entities

Claim Construction Is Ultimately A Question Of Law But May Involve Underlying Factual Questions

2010 KSR Guidelines Update, 75 FR (September 1, 2010) Updated PTO guidelines on obviousness determinations in a post KSR World

Does Teva Matter? Edward R. Reines December 10, 2015

United States Court of Appeals for the Federal Circuit

LIMELIGHT V. AKAMAI: LIMITING INDUCED INFRINGEMENT

United States Court of Appeals for the Federal Circuit

United States Court of Appeals for the Federal Circuit

An Empirical Study of the Role of the Written Description Requirement in Patent Prosecution

PATENT CASE LAW UPDATE

Advanced Topics in Double Patenting

(Serial No. 29/253,172) IN RE TIMOTHY S. OWENS, SHEILA M. KELLY, ROBERT M. LYNCH, IV, JASON C. CAMPBELL, and PHILIP E.

United States Court of Appeals for the Federal Circuit

Chapter Patent Infringement --

UNITED STATES DISTRICT COURT CENTRAL DISTRICT OF CALIFORNIA CIVIL MINUTES GENERAL

Moba v. Diamond Automation, Inc.: Questioning the Spearate Written Description Requirement

By Rebecca M. McNeill

2012 Winston & Strawn LLP

America Invents Act (AIA) The Patent Reform Law of 2011 Initial Summary

Alice: Making Step Two Work Author: James Lampert, retired from WilmerHale

For a patent to be valid, it needs to be useful, novel, nonobvious, and adequately

Art. 123(2) EPC ADDED MATTER A US Perspective. by Enrica Bruno Patent Attorney. Steinfl & Bruno LLP Intellectual Property Law

Prosecuting Patent Applications: Establishing Unexpected Results

Deputy Commissioner for Patent Examination Policy

Abstract. Keywords. Kotaro Kageyama. Kageyama International Law & Patent Firm, Tokyo, Japan

One Step Outside the Country, One Step Back from Patent Infringement

APPENDIX 1 THE CURRENT AUSTRALIAN TESTS SUFFICIENCY

2 Tex. Intell. Prop. L.J. 59. Texas Intellectual Property Law Journal Fall, Recent Development RECENT DEVELOPMENTS IN PATENT LAW

Obvious to Try? The Slippery Slope of Biotechnology

Life Science Patent Cases High Court May Review: Part 1

United States Court of Appeals for the Federal Circuit

ENZo BIOCHEM, INC. v. GEN-PROBE, INC.

EXTRATERRITORIAL INFRINGEMENT CERTIORARI PETITION IN THE LIFE TECHNOLOGIES CASE

A Patent Doctrine without Bounds: The "Extended" Written Description Requirement

United States Court of Appeals for the Federal Circuit THOMSON S.A., Plaintiff-Appellant, QUIXOTE CORPORATION and DISC MANUFACTURING, INC.

Supreme Court s New Standard of Review for Claim Construction

Case 1:06-cv DFH-TAB Document 11 Filed 05/24/06 Page 1 of 8 PageID #: 24

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WASHINGTON AT SEATTLE I. INTRODUCTION

Transcription:

Recent Decisions Affecting Patent Law IPO Annual Meeting 2010 By: Meg Boulware Baker & McKenzie International is a Swiss Verein with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a partner means a person who is a partner, or equivalent, in such a law firm. Similarly, reference to an office means an office of any such law firm.

Ariad v. Lilly, 598 F. 3d 1336 ( Fed Cir. 2010) Section 112 first paragraph includes separate written description and enablement requirements. Subject matter of patent active and inactive form of a protein, NFkB, that mediates human immune response by producing proteins know as cytokines. Important discovery that has implications for a number of disease states.

Claims to the following compositions: 1. Specific inhibitors to NFkB molecule that inactivates NFkB, one example in specification the naturally occurring I-kB. 2. Dominantly interfering molecule binds DNA site in nucleus but does not produce immune response. 3. Decoy molecules mimics binding site in nucleus, prophetic examples provided in specification.

Federal Circuit agreed with Lilly the specification shall contain a written description of the invention and [we] hold that 112, first paragraph, contains two separate description requirements: a written description [i] of the invention, and [ii] of the manner and process of making and using [the invention]. 35 U.S.C. 112, 1 (emphasis added). 598 F.3d at 1344

Federal Circuit Reasoning Genus claimed that can include hundreds of compounds, but species not described in specification. Claims recited a problem to be solved while claiming all solutions. The decoy molecules are prophetic examples of desired outcome not sufficient for unpredictable biotech art.

Federal Circuit Majority Patent is not a hunting license or a reward for basic research. BUT multiple concurring and dissenting opinions.

Other Opinions J. Gajarsa concurs but states: the text of 112 paragraph 1 is the model of legislative ambiguity up to Congress to clarify. J. Newman: The importance of 101 to patentability of this subject matter was submerged in rhetoric of measuring the patent validity under the 112 requirements.

Dissents Now Chief J. Rader: Strong dissent 112 while cumbersome is unambiguous. No statutory support for separate written description requirement from enablement; majority opinion is judicial adventurism. J. Linn agreed no separate written description requirement apart from enablement. Ariad did not file Pet. for Cert. to Supreme Court.

Ariad Applications Patent Prosecution No Change Practioners always cautioned to provide as many examples in unpredictable arts as possible. Litigation and Freedom to Operate Change. Ariad provides more viable attack under 112 for generic claims.

Telecordia v. Lucent F.3d ( Fed Cir 2010) Application of means-plus function claim interpretation for black box drawings. Claim construction of monitoring means to be interpreted under 112 6. The patent showed black boxes without description of the inner circuitry and challenged for lack of description to support means-plus function.

Technology Makes a Difference Federal Circuit agreed with district court that credible expert testimony was not refuted that ordinary artisan would understand the link between the controller and the monitoring function cited in the claim. Patent not invalid under 112 Decision underscores the difference in predictable and unpredictable technology. Comfort to those dealing in technology with known structures.

SEB S. A. v. Montgomery Ward, 594 F. 3d 1360 ( Fed Cir. 2010) Ignoring possible patent protection can lead to finding of inducement of infringement.

Factual Background Manufacturer of deep fryers copied a patented product and sold to retailers in the US. President of the manufacturer that copied the patent is inventor of US patents. Manufacturer commissioned a patent search, but neglected to tell the patent attorney about copying the design and got a clean report on patent infringement.

Holding Was manufacturer liable for inducement and had knowledge of the patent to satisfy the statutory requirement? No direct evidence of knowledge of the patent. However, the record in the trial court supports deliberate disregard of a known risk and a finding of inducement. Federal Circuit states this case does not set the outer limits on inducement.